SCHEMBL30944233

SCHEMBL30944233

CC(=O)c1ccc2c(-c3ccncc3)c(-c3ccc(F)cc3)nn2c1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 0.70
CSNK1D P48730 4/20 0.68
CSNK1E P49674 3/20 0.68
CSNK1A1 P48729 2/20 0.68
EGFR P00533 1/20 0.57
RAF1 P04049 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
ADORA2A P29274 1/20 0.57
ADORA2B P29275 1/20 0.57
ADORA1 P30542 1/20 0.57
GSK3B P49841 1/20 0.57
MAPK13 O15264 1/20 0.43
MAPK12 P53778 1/20 0.43
MAPK11 Q15759 1/20 0.43
SRC P12931 1/20 0.43
BRAF P15056 1/20 0.43
KDR P35968 1/20 0.43
GRIA1 P42261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30944230 0.89 MAPK14 (0.72) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL5400284 0.88 MAPK14 (0.70) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL30944261 0.85 MAPK14 (0.64) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL5384440 0.83 MAPK14 (1.00) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL5391299 0.81 MAPK14 (1.00) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL5388978 0.77 MAPK14 (1.00) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL30944213 0.76 MAPK14 (0.74) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL5379805 0.76 MAPK14 (1.00) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
SCHEMBL30944242 0.74 MAPK14 (0.70) MAPK14CSNK1DCSNK1ECSNK1A1EGFR
Gw434756X SCHEMBL5385166 0.73 MAPK14 (1.00) MAPK14CSNK1DCSNK1ECSNK1A1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638448-A1 CONJUGATES COMPRISING ANTIFUNGALS AND CASEIN KINASE (CK1) INHIBITORS AND METHODS OF USE THEREOF Bright Angel Therapeutics Inc. (CA) 2025-10-29 EP disclosed
WO-2024130408-A1 CONJUGATES COMPRISING ANTIFUNGALS AND CASEIN KINASE (CK1) INHIBITORS AND METHODS OF USE THEREOF BRIGHT ANGEL THERAPEUTICS INC. (CA) 2024-06-27 WO disclosed